Early research (Phase 1)Study completedNCT02710500What this trial is testingRAAVrh74.MHCK7.DYSF.DV for Treatment of DysferlinopathiesWho this might be right forDysferlinopathy Sarepta Therapeutics, Inc. 2
Large-scale testing (Phase 3)Study completedNCT00527228What this trial is testingDeflazacort in DysferlinopathiesWho this might be right forLGMD2BMiyoshi MyopathyDysferlinopathy Ludwig-Maximilians - University of Munich 25
Not applicableUnknownNCT01676077What this trial is testingClinical Outcome Study for DysferlinopathyWho this might be right forDysferlinopathyLGMD2B Now Classified as LGMDR2Miyoshi Myopathy Newcastle-upon-Tyne Hospitals NHS Trust 200
Not applicableStudy completedNCT06507215What this trial is testingDysferlinopathy Protein in Peripheral Blood Monocytes.Who this might be right forMuscular DystrophiesLimb-Girdle Muscular Dystrophy Type 2BMiyoshi Myopathy+1 more Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 149
Not applicableEnrolling By InvitationNCT04824040What this trial is testingClinical, Immunological, Morphological and Genetic Characteristics of Patients With Dysferlinopathy (LGMD R2) in the RFWho this might be right forDysferlinopathyMiyoshi MyopathyLGMDR2+1 more Artgen Biotech 100
Not applicableActive Not RecruitingNCT04475926What this trial is testingThe Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical PracticeWho this might be right forLimb-girdle Muscular Dystrophy Sarepta Therapeutics, Inc. 205
Early research (Phase 1)Ended earlyNCT01863004What this trial is testingProteasomal Inhibition for Patients With Mis-sense Mutated DysferlinWho this might be right forDysferlinopathy University Hospital, Basel, Switzerland 3
Not applicableStudy completedNCT07035145What this trial is testingObservational Cohort Study of Dysferlinopathy in ChinaWho this might be right forDysferlinopathy Peking University First Hospital 160